CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer.

Front Oncol · 2024 · PMC11586233 · PMID 39588301

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This finding was validated in the meta-GEO database, where patients with high CXCR6 expression showed a trend toward better OS compared to those with low expression ( Figure 1G ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.